We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$238M
AUM Growth
+$3.32M
Cap. Flow
-$2.31M
Cap. Flow %
-0.97%
Top 10 Hldgs %
40.65%
Holding
138
New
3
Increased
34
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
CTMX icon
CytomX Therapeutics
CTMX
+$1.42M
2
PSLV icon
Sprott Physical Silver Trust
PSLV
+$566K
3
Q
Qnity Electronics Inc
Q
+$357K
4
CB icon
Chubb
CB
+$189K
5
WU icon
Western Union
WU
+$148K

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$2.1M
2
PYXS icon
Pyxis Oncology
PYXS
+$611K
3
DD icon
DuPont de Nemours
DD
+$452K
4
SLV icon
iShares Silver Trust
SLV
+$441K
5
CTAS icon
Cintas
CTAS
+$290K

Sector Composition

Rank Sector Weight
1 Financials 21.72%
2 Consumer Staples 17.43%
3 Industrials 12.82%
4 Healthcare 12.68%
5 Technology 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
76
RTX Corp
RTX
$262B
$585K 0.25%
3,188
+52
+2% +$9.03K
FDX icon
77
FedEx
FDX
$75.9B
$560K 0.24%
1,938
+20
+1% +$5.25K
PIPR icon
78
Piper Sandler
PIPR
$5.25B
$546K 0.23%
6,432
-40
-0.6% -$3.38K
WMB icon
79
Williams Companies
WMB
$91.4B
$534K 0.22%
8,878
– –
SO icon
80
Southern Company
SO
$108B
$512K 0.22%
5,875
– –
MPLX icon
81
MPLX
MPLX
$58B
$507K 0.21%
9,500
+2,000
+27% +$104K
FUN icon
82
Cedar Fair
FUN
$1.94B
$432K 0.18%
28,166
– –
WY icon
83
Weyerhaeuser
WY
$17.6B
$429K 0.18%
18,105
– –
CL icon
84
Colgate-Palmolive
CL
$75.3B
$421K 0.18%
5,334
– –
GOOG icon
85
Alphabet (Google) Class C
GOOG
$4.32T
$410K 0.17%
1,308
-38
-3% -$10.9K
WES icon
86
Western Midstream Partners
WES
$19B
$399K 0.17%
10,100
+3,600
+55% +$140K
EVRG icon
87
Evergy
EVRG
$20B
$399K 0.17%
5,500
– –
CPT icon
88
Camden Property Trust
CPT
$11.4B
$393K 0.17%
3,572
– –
AMP icon
89
Ameriprise Financial
AMP
$47.9B
$392K 0.17%
800
– –
CHDN icon
90
Churchill Downs
CHDN
$6.01B
$373K 0.16%
3,280
-1,100
-25% -$114K
DD icon
91
DuPont de Nemours
DD
$18.1B
$348K 0.15%
2,888
-4,015
-58% -$452K
ENB icon
92
Enbridge
ENB
$123B
$344K 0.14%
7,197
– –
IVV icon
93
iShares Core S&P 500 ETF
IVV
$881B
$344K 0.14%
502
– –
BRK.B icon
94
Berkshire Hathaway Class B
BRK.B
$1.06T
$333K 0.14%
663
– –
KIM icon
95
Kimco Realty
KIM
$17.6B
$330K 0.14%
16,303
– –
SLB icon
96
SLB Ltd
SLB
$70.4B
$325K 0.14%
8,480
– –
Q
97
Qnity Electronics Inc
Q
$28.4B
$325K 0.14%
+4,200
New +$357K
JCI icon
98
Johnson Controls International
JCI
$86.2B
$322K 0.14%
2,685
– –
ITRN icon
99
Ituran Location and Control
ITRN
$1.11B
$321K 0.14%
7,475
– –
FITB
100
Fifth Third Bancorp
FITB
$53.8B
$316K 0.13%
6,753
– –
2 3
4
5 6

Similar funds

HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
YP
YANKCOM Partnership Yankton, South Dakota $243M AUM 21.59% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return

Schulhoff & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Schulhoff & Co held 138 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schulhoff & Co's Q4 2025 filing shows 3 new, 34 increased, 36 reduced and 6 closed positions. Its largest new stake was CytomX Therapeutics: 374,850 shares worth $1.6M. The largest sale was Avadel Pharmaceuticals, an estimated $2.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Industrials.

  • Schulhoff & Co's largest Q4 2025 buy was CytomX Therapeutics: 374,850 shares worth $1.6M.
  • Schulhoff & Co added most to Sprott Physical Silver Trust in Q4 2025, an estimated $566K increase.
  • Schulhoff & Co's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $452K.
  • Schulhoff & Co fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $2.1M.
  • Schulhoff & Co's ten largest holdings make up 41% of its $238M portfolio in Q4 2025.
  • Schulhoff & Co opened 3 new positions and closed 6 in Q4 2025.
  • Schulhoff & Co's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.